Article
RAS mutations contribute to evolution of chronic myelomonocytic leukemia to the proliferative variant.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Apr 2010
Ricci Clara, Fermo Elisa, Corti Stefania, Molteni Mauro, Faricciotti Alessio, Cortelezzi Agostino, Lambertenghi Deliliers Giorgio, Beran Miloslav, Onida Francesco
Abstract excerpt
PURPOSE: The biological and clinical heterogeneity of chronic myelomonocytic leukemia features renders its classification difficult. Moreover, because of the limited knowledge of the mechanisms involved in malignant evolution, chronic myelomonocytic leukemia remains a diagnostic and therapeutic challenge and a poor prognosis disease. We aimed to verify the biological and clinical significance of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
